UCB与诺华签署价值达15亿美元合作协议，研发并商业化抗帕金森病药物
作者：yuanxc 来源：互联网 点击数：0 更新时间：2021/12/9 15:09:40
相关连接
Iddol: The company has currently halted the production of vitamin B12.
Latest update: The supply of vitamin E feed grade from Zhejiang Pharmaceutical has been suspended as of today.
Latest news: The price of vitamin E has dropped rapidly, and some manufacturers have stopped reporting it.
57亿美元！诺华与分子胶企业达成战略合作
诺华重磅肺癌药物“卡马替尼”获批新适应症
诺华创新药物“伊普可泮”IgA肾病适应症在中国获批
Latest News: Jiangxi Tianxin Pharmaceutical Co., Ltd. resumes quotations for Vitamin B1 Nitrate starting from September 12th.
The latest price of feed-grade Vitamin E from NHU on September 10th
Latest update: The supply of vitamin E feed grade from Zhejiang Pharmaceutical has been suspended as of today.
Latest news: The price of vitamin E has dropped rapidly, and some manufacturers have stopped reporting it.
57亿美元！诺华与分子胶企业达成战略合作
诺华重磅肺癌药物“卡马替尼”获批新适应症
诺华创新药物“伊普可泮”IgA肾病适应症在中国获批
Latest News: Jiangxi Tianxin Pharmaceutical Co., Ltd. resumes quotations for Vitamin B1 Nitrate starting from September 12th.
The latest price of feed-grade Vitamin E from NHU on September 10th